Import Cinchocaine Hcl — Buy in Bulk from Supplier in China

Cinchocaine HCl is a pharmaceutical-grade local anesthetic supplied by Jinan Chenghui Shuangda Chemical Co., Ltd. in Shandong, China. This compound meets USP29 standards, ensuring compliance with stringent pharmaceutical requirements for purity and efficacy. The product is designed for medical applications where consistent performance and safety are critical, such as minor surgical procedures and topical anesthetic formulations.

The active ingredient is a synthetic ester-type local anesthetic, typically presenting as a white or almost white crystalline powder. It is soluble in water and alcohol, with a molecular formula of C17H27NO3 and a molecular weight of 293.4 g/mol. Cinchocaine HCl is known for its rapid onset and prolonged duration of action, making it suitable for procedures requiring sustained anesthesia. Standard industry grades for pharmaceutical use often include a minimum assay of 99.0%, with residual solvents and heavy metals controlled to ppm levels.

This product is primarily sourced by hospitals, clinics, and pharmaceutical manufacturers for use in injectable or topical anesthetic preparations. Buyers typically request bulk quantities, with packaging options including sealed drums or bags under nitrogen to preserve stability. Trade terms such as FOB or CIF are commonly negotiated, and compliance with ISO and GMP certifications is expected for pharmaceutical-grade materials.

Jinan Chenghui Shuangda Chemical Co., Ltd. is based in Shandong, China, at No15, Huaxin Road, Jinan 250100. The company operates as an imported-tier supplier in the pharmaceutical chemicals sector, specializing in active pharmaceutical ingredients (APIs) and intermediates. Its profile indicates a focus on compliance with international pharmaceutical standards, as evidenced by the USP29-grade Cinchocaine HCl offering.

The supplier’s trust tier is classified as harbor, and while its response rate is currently listed as 0.00%, this may reflect limited recent activity rather than capability. The company’s product descriptions emphasize adherence to quality documentation, including Certificates of Analysis (CoA), which are critical for pharmaceutical buyers. However, no additional details such as production capacity, certifications beyond USP29, or client references are provided in the available data.